LES005.3.09B-Renovia-Agreement-30Oct18-FINAL
Recent Press Releases
- Renovia Announces FDA 510(k) Clearance of Next-Generation leva® Pelvic Digital Therapeutic
- Renovia Study Results Published in Neurology and Urodynamics Show Positive Results for leva® Pelvic Digital Therapeutic in Treating Female Urinary Incontinence
- Renovia Inc. Nominated for MedTech Company of the Year at the New England Venture Capital Association’s 2019 NEVYs Awards
- Renovia Names Jim O’Connor as General Counsel & Senior Vice President, Strategic Development
- Renovia Appoints John A. Fallon, M.D. to its Board of Directors
- Renovia Launches “REDUCE” – a Multi-Center Randomized Controlled Trial to Study Next-Generation leva® Pelvic Digital Therapeutic System for Urinary Incontinence